NATURAL ALTERNATIVES INTL (NAII)

US6388423021 - Common Stock

4.15  -0.05 (-1.19%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to NAII. NAII was compared to 37 industry peers in the Personal Care Products industry. NAII may be in some trouble as it scores bad on both profitability and health. NAII has a expensive valuation and it also scores bad on growth.



1

1. Profitability

1.1 Basic Checks

NAII had negative earnings in the past year.
In the past year NAII has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: NAII reported negative net income in multiple years.
Of the past 5 years NAII 4 years had a positive operating cash flow.

1.2 Ratios

NAII has a worse Return On Assets (-5.27%) than 66.67% of its industry peers.
NAII has a Return On Equity (-10.61%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -5.27%
ROE -10.61%
ROIC N/A
ROA(3y)1.58%
ROA(5y)2.48%
ROE(3y)2.06%
ROE(5y)3.48%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 5.30%, NAII is not doing good in the industry: 88.89% of the companies in the same industry are doing better.
NAII's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for NAII so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 5.3%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-29.24%
GM growth 5Y-18.78%

3

2. Health

2.1 Basic Checks

NAII does not have a ROIC to compare to the WACC, probably because it is not profitable.
NAII has more shares outstanding than it did 1 year ago.
The number of shares outstanding for NAII has been reduced compared to 5 years ago.
Compared to 1 year ago, NAII has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 1.59, we must say that NAII is in the distress zone and has some risk of bankruptcy.
NAII's Altman-Z score of 1.59 is on the low side compared to the rest of the industry. NAII is outperformed by 66.67% of its industry peers.
A Debt/Equity ratio of 0.18 indicates that NAII is not too dependend on debt financing.
The Debt to Equity ratio of NAII (0.18) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Altman-Z 1.59
ROIC/WACCN/A
WACC7.15%

2.3 Liquidity

NAII has a Current Ratio of 2.56. This indicates that NAII is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.56, NAII is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
A Quick Ratio of 1.50 indicates that NAII should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.50, NAII is in line with its industry, outperforming 58.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.56
Quick Ratio 1.5

0

3. Growth

3.1 Past

NAII shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1211.77%.
Looking at the last year, NAII shows a very negative growth in Revenue. The Revenue has decreased by -22.01% in the last year.
The Revenue has been decreasing by -3.83% on average over the past years.
EPS 1Y (TTM)-1211.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-179.03%
Revenue 1Y (TTM)-22.01%
Revenue growth 3Y-13.93%
Revenue growth 5Y-3.83%
Sales Q2Q%-2.41%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NAII. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for NAII!.
Industry RankSector Rank
Dividend Yield N/A

NATURAL ALTERNATIVES INTL

NASDAQ:NAII (1/14/2025, 8:00:01 PM)

4.15

-0.05 (-1.19%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)11-06 2024-11-06/amc
Earnings (Next)02-11 2025-02-11
Inst Owners30.96%
Inst Owner Change0%
Ins Owners21.29%
Ins Owner Change0%
Market Cap25.73M
Analysts0
Price TargetN/A
Short Float %0.09%
Short Ratio0.55
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.23
P/FCF N/A
P/OCF N/A
P/B 0.32
P/tB 0.32
EV/EBITDA N/A
EPS(TTM)-1.45
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.85
FCFYN/A
OCF(TTM)-1.52
OCFYN/A
SpS18.22
BVpS12.93
TBVpS12.93
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.27%
ROE -10.61%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 5.3%
FCFM N/A
ROA(3y)1.58%
ROA(5y)2.48%
ROE(3y)2.06%
ROE(5y)3.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-29.24%
GM growth 5Y-18.78%
F-Score2
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 44.07%
Cap/Sales 1.8%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.56
Quick Ratio 1.5
Altman-Z 1.59
F-Score2
WACC7.15%
ROIC/WACCN/A
Cap/Depr(3y)339.43%
Cap/Depr(5y)250.14%
Cap/Sales(3y)8.97%
Cap/Sales(5y)6.72%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1211.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-179.03%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-22.01%
Revenue growth 3Y-13.93%
Revenue growth 5Y-3.83%
Sales Q2Q%-2.41%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-473.61%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-137.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-185.12%
OCF growth 3YN/A
OCF growth 5YN/A